FIND DOCTORS
-
Name: Ma, Xuejun
Department: RADIATION ONCOLOGY
Title:Associate ProfessorEducation & Professional Experience 2007- Associate Professor, Department of Radiation Oncology, Fudan University Cancer Hospital.
2004– 2005 Clinical fellow, Department of Radiation Oncology, National University Hospital, Singapore
2000-2006 Attending of Radiation Oncologist, Department of Radiation Oncology, Fudan University Cancer Hospital.
1996– 1998 Research fellow, Department of Basic Radiation Medicine, School of Medicine, Tokyo University, Japan
1992-2000 Resident, Department of Radiation Oncology, Fudan University Cancer Hospital.
1986-1992 M.D., Faculty of Medicine, Shanghai Medical University
Specialty Lymphoma, GI/GU Cancer Research Lymphoma Publication （1）MA XJ, PAN ZQ Whole abdominopelvic irradiation of non-Hodgkin’s lymphoma. China Oncology, 2000, 10:423-425
（2）MA XJ, GUO XM, ZHU J, et al. Postoperative Radiotherapy for stage II/III rectal cancer. China Oncology, 2006;16(3):205-207
（3）MA XJ, GUO Y, LU JJ, et al. Combined Chemotherapy and External Beam Radiation for Stage IE and IIE NK/T- Cell Lymphoma of Nasal Cavity. Int.J. Radiat. Oncol. Biol. Phys. 2006; 66 (3, suppl): S504
（4）MA XJ, LU JJ, LOH T, et al. CT findings at the primary site of nasopharyngeal carcinoma 4 months after definitive radiotherapy: what is the significance of residual disease. The Laryngoscope, 2006;116:2162-2165
（5）MA XJ, ZHANG Z, LU JJ, et al. Significance of CT scan in the early follow-up after definitive radiotherapy of nasopharyngeal cancer. China Oncology, 17(2):151-154
（6）WANG BY, LU JJ, MA XJ, et al. Combined Chemotherapy and External Beam Radiation for Stage IE and IIE Natural Killer T-Cell Lymphoma of Nasal Cavity. Leukemia and Lymphoma, 2007; 48(2):396-402
（7）WANG BY, HONG XN, MA XJ Analysis of prognostic factors of nasal NK/T cell lymphoma. Journal of Chinese Oncology, 2006; 28(7): 523-525.
（8）GUO Y, LU JJ, MA XJ, et al Combined Chemoradiation for the Management of Nasal Natural Killer (NK)/T-cell Lymphoma: Elucidating the significance of Systemic Chemotherapy. Oral Oncol, 2008; 44:23-30.
（9）MA X, Guo Y, Pan Z, et ak. A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract. Radiother & Oncol 2009;93:492-497Awards Year 2003 Model Staff of Cancer Hospital, Fudan University Out-patient Schedule Tuesday afternoon
